首页> 外国专利> OXYGEN SUBSTITUTED DERIVATIVES OF NUCLEOPHILE-NITRIC OXIDE ADDUCTS AS NITRIC OXIDE DONOR PRODRUGS

OXYGEN SUBSTITUTED DERIVATIVES OF NUCLEOPHILE-NITRIC OXIDE ADDUCTS AS NITRIC OXIDE DONOR PRODRUGS

机译:氧取代一氧化氮一氧化氮衍生物的衍生物

摘要

There are disclosed cardiovascularly active compoundspossessing antihypertensive properties, and pharmaceuticalcompositions containing these agents and a method of treatingcardiovascular disorders with the compounds. The activecomponents of the pharmaceutical compositions are compoundsof formula (I) wherein R1 and R2 are independently chosenfrom straight chain and branched chain alkyl and olefinicgroups, which may be unsubstituted or substituted; or R1and R2 together with the nitrogen atom they are bonded toform a heterocyclic group; and R3 is a pharmaceuticallyacceptable organic group selected from alkyl and olefinicgroups which may be unsubstituted or substituted; acyl, asulfonyl, sulfinyl, sulfenyl, carbonate, or carbamatederivative; or R3 is a group of the formula:(CH2)n ONN(O)NR1R2, wherein n is 2-8, and R1 and R2 areas described above. Novel compounds are disclosed whereinat least one of R1, R2 and R3 is an olefinic group orheteroatom-substituted straight or branched chain alkyl orolefinic group. Novel methods of synthesizing thecompounds are also disclosed.
机译:公开了具有心血管活性的化合物具有降压作用,具有药物包含这些试剂的组合物和治疗方法心血管疾病与化合物。主动药物组合物的成分是化合物式(I)的化合物,其中R 1和R 2独立地选择来自直链和支链的烷基和烯烃可以是未取代或取代的基团;或R1和R2与它们所键合的氮原子一起形成杂环基R3是药物可接受的选自烷基和烯烃的有机基团可以是未取代或取代的基团;酰基磺酰基,亚磺酰基,亚磺酰基,碳酸盐或氨基甲酸酯衍生物;或R3是下式的一组:(CH2)n ONN(O)NR1R2,其中n为2-8,R1和R2为如上所述。公开了新颖的化合物,其中R1,R2和R3中的至少一个是烯基或杂原子取代的直链或支链烷基或烯基。合成的新方法还公开了化合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号